Merger documents

Explore the information relating to the merger

Press releases

Presentations

Documents related to the offering circular

Financial information referenced in the offering circular

Documents related to the DSM EGM

Explore more

Results center

All the key financial performance information published by DSM and Firmenich prior to our merger, plus financial information published by dsm-firmenich.

Read more
Investors

Two global leaders in science and innovation have joined forces to become dsm-firmenich, creating a world of potential for investors.

Read more
Share performance

Tools to track your share performance.

Read more

Merger documents

Explore the information relating to the merger

Press releases

DSM-Firmenich AG announces the successful placement of c. 6.7 million existing DSM-Firmenich ordinary shares through an accelerated bookbuild offering for a total amount of €733 million

DSM-Firmenich AG launches the sale of up to c. 6.7 million existing DSM-Firmenich ordinary shares through an accelerated bookbuild offering

Final results of the exchange offer: 96.1% of DSM ordinary shares tendered

dsm-firmenich first day of trading on Euronext Amsterdam

Exchange offer declared unconditional

Second supplement to offering circular

DSM and Firmenich have obtained all competition clearances

Acceptance period second extension announcement

DSM and Firmenich have obtained competition clearance from the European Commission

Acceptance period extension announcement

DSM announces results of EGM

Exchange offer & EGM announcement

dsm-firmenich update on public exchange offer process

DSM and Firmenich confirm leadership team

Merger announcement (EN)

Merger announcement (FR)

Merger announcement (DE)

Merger announcement (NL)

Presentations

EGM presentation – 23 Jan

Investor presentation - 22 Nov

Investor presentation - 13 June (EN)

Capital markets day presentation - 13 June (EN)

Investor call transcript - 31 May (EN)

Investor presentation - 31 May (EN)

Media presentation (EN)

Documents related to the offering circular

Second supplement to the offering circular

Supplement to the offering circular

Offering circular

U.S. investor letter

Financial information referenced in the offering circular

Firmenich Q1 2023 trading update

Firmenich annual report for the financial year ended 2022

Firmenich interim consolidated financial statements for the six months ended 31 December 2021

Firmenich annual report for the financial year ended 2021

Firmenich interim consolidated financial statements for the six months ended 31 December 2020

Firmenich annual report for the financial year ended 2020

DSM Q3 2022 trading update

DSM HY 2022 financial statements & auditor's report

DSM consolidated financial statements for the financial years ended 31 December 2021 and 2020 & auditor’s report

DSM integrated annual report 2021

DSM integrated annual report 2020

DSM integrated annual report 2019

Documents related to the DSM EGM

EGM voting results

EGM minutes

Position statement

Convocation notice, agenda & notes

Form B - proxy

Form A - notification

DSM virtual meeting manual & FAQ

Form C - voting instructions

Proposed amendment to the Articles of Association for the conversion of DSM N.V. into DSM B.V.

DSM's policy regarding hybrid shareholder meetings

Merger proposal

Merger proposal: Schedule A

Merger proposal: Schedule B

Merger proposal: Schedule C

Merger proposal: Schedule D (Auditor's report)

Merger Proposal: Explanatory notes

Explanatory Notes: Schedule (Auditor’s assurance report)

Explore more

Results center

Investors

Share performance